BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6538019)

  • 1. HLA antigens in Guillain-Barré syndrome.
    Kaslow RA; Sullivan-Bolyai JZ; Hafkin B; Schonberger LB; Kraus L; Moore MJ; Yunis E; Williams RM
    Neurology; 1984 Feb; 34(2):240-2. PubMed ID: 6538019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens in the Guillain-Barré syndrome.
    Winer JB; Briggs D; Welsh K; Hughes RA
    J Neuroimmunol; 1988 Apr; 18(1):13-6. PubMed ID: 2831249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA typing and Guillain-Barré syndrome.
    Latovitzki N; Suciu-Foca N; Penn AS; Olarte MR; Chutorian AM
    Neurology; 1979 May; 29(5):743-5. PubMed ID: 571573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological observations in Guillain-Barré syndrome.
    Sepcić J; Morović M; Rukavina D; Sepić-Grahovac D
    Acta Med Iugosl; 1990; 44(4):265-74. PubMed ID: 2091432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination.
    Kaplan JE; Katona P; Hurwitz ES; Schonberger LB
    JAMA; 1982 Aug; 248(6):698-700. PubMed ID: 7097920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome after varicella-zoster infection. Case report.
    Arruda WO; Aguiar LR; Sandoval PR
    Arq Neuropsiquiatr; 1987 Dec; 45(4):430-3. PubMed ID: 3449027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal Guillain-Barré syndrome after the national influenza immunization program.
    Keenlyside RA; Schonberger LB; Bregman DJ; Bolyai JZ
    Neurology; 1980 Sep; 30(9):929-33. PubMed ID: 6252515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-antigens in Guillain-Barré syndrome.
    Hafez M; Nagaty M; Al-Tonbary Y; el-Shennawy FA; el-Mongui A; el-Sallab S; Attia S
    J Neurogenet; 1985 Sep; 2(4):285-90. PubMed ID: 4087075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group.
    Safranek TJ; Lawrence DN; Kurland LT; Culver DH; Wiederholt WC; Hayner NS; Osterholm MT; O'Brien P; Hughes JM
    Am J Epidemiol; 1991 May; 133(9):940-51. PubMed ID: 1851395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
    Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
    Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR antigens in Mexican patients with Guillain-Barré syndrome.
    Gorodezky C; Varela B; Castro-Escobar LE; Chávez-Negrete A; Escobar-Gutiérrez A; Martínez-Mata J
    J Neuroimmunol; 1983 Feb; 4(1):1-7. PubMed ID: 6401765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    McCombe PA; Csurhes PA; Greer JM
    J Neuroimmunol; 2006 Nov; 180(1-2):172-7. PubMed ID: 16935351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome in recipients of A/New Jersey influenza vaccine.
    Marks JS; Halpin TJ
    JAMA; 1980 Jun; 243(24):2490-4. PubMed ID: 6247520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
    Taylor WA; Hughes RA
    J Neuroimmunol; 1989 Sep; 24(1-2):33-9. PubMed ID: 2808686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis.
    Stewart GJ; Pollard JD; McLeod JG; Wolnizer CM
    Ann Neurol; 1978 Sep; 4(3):285-9. PubMed ID: 718142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Guillain-Barré syndrome.
    Kaslow RA; Sullivan-Bolyai JZ; Holman RC; Hafkin B; Dicker RC; Schonberger LB
    Neurology; 1987 Apr; 37(4):685-8. PubMed ID: 3561781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome and the 1978-1979 influenza vaccine.
    Hurwitz ES; Schonberger LB; Nelson DB; Holman RC
    N Engl J Med; 1981 Jun; 304(26):1557-61. PubMed ID: 7231501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.